The effectiveness of converting to sirolimus versus continuation of a tacrolimus-based immunosupression regimen in low-risk recipients of a first kidney transplant.

Trial Profile

The effectiveness of converting to sirolimus versus continuation of a tacrolimus-based immunosupression regimen in low-risk recipients of a first kidney transplant.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 May 2013

At a glance

  • Drugs Sirolimus (Primary) ; Tacrolimus (Primary) ; Mycophenolate sodium; Prednisone
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2012 New trial record
    • 19 Jul 2012 Results presented at the 24th International Congress of the Transplantation Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top